Basil Michelle L's Form 4 filing
Haemonetics Corp (HAE) · filed May 17, 2024
- Accession no.
- 0001127602-24-015872
- Filed
- May 17, 2024
- Trade date
- May 15-16, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $94.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Basil Michelle LCIK 0001699629 | Officer (EVP and General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 15, 2024 | Common Stock | FTax withholdingDisposed | −416 | $96.49 | −$40,139.84 | 31,856 | Direct | |
| May 16, 2024 | Common Stock | FTax withholdingDisposed | −446 | $94.80 | −$42,280.8 | 31,410 | Direct | |
| May 16, 2024 | Common Stock | SSaleDisposed | −985 | $96.14 | −$94,697.9 | 30,425 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.